Bioanalytical Services
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
40
NCT05169671
Safety, Tolerability, and Pharmacokinetics Study of ATH-1020
Phase: Phase 1
Role: Collaborator
Start: Mar 30, 2022
Completion: Sep 9, 2022
NCT05511558
A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)
Start: Jul 13, 2022
Completion: Oct 26, 2022
Loading map...